RNLXY

RENALYTIX PLC SP/ADR by Renalytix plc (RNLXY)

About RENALYTIX PLC SP/ADR by Renalytix plc (RNLXY)

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.

Details

Daily high

$0.25

Daily low

$0.22

Price at open

$0.24

52 Week High

$0.89

52 Week Low

$0.12

Market cap

39.7M

Dividend yield

0.00%

Volume

104,564

Avg. volume

14,972

P/E ratio

-.66

RENALYTIX PLC SP/ADR by Renalytix plc News